Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.75B |
| 2 |
TSMC
TSM
|
+$1.31B |
| 3 |
Eaton
ETN
|
+$1.17B |
| 4 |
Analog Devices
ADI
|
+$1.13B |
| 5 |
GE HealthCare
GEHC
|
+$1.12B |
Top Sells
| 1 |
Amazon
AMZN
|
+$2.14B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.73B |
| 3 |
Apple
AAPL
|
+$1.6B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.54B |
| 5 |
UnitedHealth
UNH
|
+$1.37B |
Sector Composition
| 1 | Technology | 26.77% |
| 2 | Healthcare | 14.55% |
| 3 | Financials | 10.98% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Arcturus Therapeutics
ARCT
$533M
| $19.9M | ﹤0.01% |
828,392
-81,851
| -9% | -$1.96M |
|
1577
Kymera Therapeutics
KYMR
$3.66B
| $19.8M | ﹤0.01% |
667,351
-178,695
| -21% | -$5.29M |
|
1578
Unisys
UIS
$290M
| $19.7M | ﹤0.01% |
5,088,700
-5,079,432
| -50% | -$19.7M |
|
|
AMAM
1579
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $19.7M | ﹤0.01% |
2,210,618
-485,446
| -18% | -$4.33M |
|
1580
National Vision
EYE
$2.09B
| $19.7M | ﹤0.01% |
1,046,393
-4,176,771
| -80% | -$78.7M |
|
1581
Novanta
NOVT
$4.22B
| $19.7M | ﹤0.01% |
123,864
-2,109
| -2% | -$336K |
|
|
ODV
1582
Osisko Development Corp
ODV
$697M
| $19.5M | ﹤0.01% |
4,001,500
+3,334,834
| +500% | +$16.3M |
|
1583
Lantheus
LNTH
$3.51B
| $19.4M | ﹤0.01% |
235,073
+177,703
| +310% | +$14.7M |
|
1584
Tyler Technologies
TYL
$22.9B
| $19.3M | ﹤0.01% |
54,349
+26,149
| +93% | +$9.27M |
|
1585
Altice USA
ATUS
$1.27B
| $19.3M | ﹤0.01% |
5,633,004
+596,448
| +12% | +$2.04M |
|
1586
QuinStreet
QNST
$982M
| $19.2M | ﹤0.01% |
1,209,201
+48,830
| +4% | +$775K |
|
|
HZNP
1587
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $19.1M | ﹤0.01% |
175,023
+18,117
| +12% | +$1.98M |
|
1588
Choice Hotels
CHH
$5.08B
| $19.1M | ﹤0.01% |
162,587
+1,094
| +0.7% | +$128K |
|
1589
Boston Properties
BXP
$12.3B
| $19.1M | ﹤0.01% |
352,049
+298,291
| +555% | +$16.1M |
|
1590
Forward Air
FWRD
$826M
| $18.8M | ﹤0.01% |
174,207
+118,132
| +211% | +$12.7M |
|
1591
Center Bancorp
CNOB
$1.32B
| $18.7M | ﹤0.01% |
1,059,048
-44,035
| -4% | -$779K |
|
1592
Shattuck Labs
STTK
$107M
| $18.7M | ﹤0.01% |
6,367,363
+8,776
| +0.1% | +$25.8K |
|
1593
Foghorn Therapeutics
FHTX
$291M
| $18.7M | ﹤0.01% |
3,015,012
-102,382
| -3% | -$635K |
|
1594
Theravance Biopharma
TBPH
$729M
| $18.6M | ﹤0.01% |
1,714,389
-759,083
| -31% | -$8.24M |
|
1595
Compass Therapeutics
CMPX
$631M
| $18.6M | ﹤0.01% |
5,681,072
-673,742
| -11% | -$2.2M |
|
1596
Century Therapeutics
IPSC
$43.8M
| $18.5M | ﹤0.01% |
5,342,983
-1,753,428
| -25% | -$6.08M |
|
1597
Rallybio
RLYB
$25M
| $18.5M | ﹤0.01% |
3,245,255
-170
| -0% | -$971 |
|
1598
Openlane
KAR
$3.1B
| $18.5M | ﹤0.01% |
1,354,225
+392
| +0% | +$5.36K |
|
1599
Climb Global Solutions
CLMB
$620M
| $18.5M | ﹤0.01% |
346,740
-40
| -0% | -$2.13K |
|
1600
Hyster-Yale Materials Handling
HY
$673M
| $18.5M | ﹤0.01% |
369,984
+90,106
| +32% | +$4.5M |
|